Tag: Transgender
Health Status, Mental Health Worsened in U.S. Transgender Adults From 2014 to 2022
Doubling seen for prevalence of frequent mental distress and depression
U.S. Supreme Court Agrees to Hear Case on Medical Care for Transgender Youth
Evidence Lacking for Gender Dysphoria Treatments for Teens
Two systematic reviews show inadequate evidence for use of treatment to suppress or lessen effect of puberty, hormone treatment
Disparities in Transgender Prostate Screening Uptake Driven by Clinicians
Clinician-led recommendations for and discussions of PSA screening explained differences between cisgender and transgender screening rates
ED Use Increased for Transgender, Gender-Diverse Medicare Beneficiaries
TGD beneficiaries more likely than cisgender beneficiaries to use emergency department for mental health care
Gender-Related Differences Seen for Self-Reported Mental Health Conditions
Cisgender individuals have lowest probability of reporting a mental health condition or unmet mental health need
Gender Minority Adults Are Vulnerable During Full Body Skin Exam
Gender queer and transgender individuals more likely to report discomfort than sexual minority cisgender females, males
2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender Persons
In 2021, 20.2 and 10.2 percent of transgender women and transgender men who had an HIV test were prescribed PrEP
Thyroid Cancer Prevalent Among Transgender Female Veterans
Estrogen gender-affirming hormone therapy may be a risk factor
Hematocrit Within Normal Range With Testosterone Gender-Affirming Therapy
Mean hematocrit ranged from 41.84 to 45.68 percent for those receiving testosterone as gender-affirming hormone therapy
